GoHealth, Inc.

  • Market Cap: Micro Cap
  • Industry: Capital Markets
  • ISIN: US38046W2044
USD
2.94
0.01 (0.34%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About GoHealth, Inc. stock-summary
stock-summary
GoHealth, Inc.
Capital Markets
GoHealth, Inc. operates a health insurance marketplace. Its technology platform leverages modern machine-learning algorithms powered by insurance behavioral data to reimagine the optimal process for helping individuals find the health insurance plan for their specific needs. The Company operates its business in four segments: Medicare-Internal; Medicare-External; Individual and Family Plans (IFP) and Other-Internal, and IFP and Other-External. The Medicare segments focus on sales of Medicare Advantage, Medicare Supplement, Medicare prescription drug plans, and Medicare Special Needs Plans (SNPs) for multiple carriers. The Medicare Internal segments primarily consist of sales of products and plans offering qualified prospects plans from multiple carriers. The Company’s employed agents offering qualified prospects plans on a carrier-specific basis, or sales of products and plans through its online platform without the assistance of its agents, which is referred as do it yourself (DIY).
Company Coordinates stock-summary
Company Details
214 West Huron Street , CHICAGO IL : 60654
stock-summary
Tel: 1 312 3868222
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 15 Schemes (6.16%)

Foreign Institutions

Held by 15 Foreign Institutions (0.99%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Clinton Jones
Chief Executive Officer, Co-Founder, Director
Mr. Rahm Emanuel
Director
Mr. Joseph Flanagan
Director
Mr. Jeremy Gelber
Director
Ms. Miriam Tawil
Director
Mr. Alex Timm
Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
94 Million
(Quarterly Results - Jun 2025)
Net Profit:
-116 Million
stock-summary
Industry

Capital Markets

stock-summary
Market cap

USD 79 Million (Micro Cap)

stock-summary
P/E

6.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

19.53%

stock-summary
Price to Book

0.41